Healthy volunteers test new drug form in early safety study
NCT ID NCT07251153
First seen Dec 18, 2025 · Last updated May 22, 2026 · Updated 22 times
Summary
This early-stage study tests two versions of a drug called vonafexor in 40 healthy adults aged 18-65. The goal is to measure how the body processes each form and whether one version interacts with other medications. Participants receive single and multiple doses, and blood samples are taken to compare drug levels. No treatment for any disease is being tested here.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE AND FEMALE VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Eurofins Optimed
RECRUITINGGières, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.